Tirzepatide is a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://jasperkuuj973058.p2blogs.com/39017076/tirzepatide-a-game-changer-for-type-2-diabetes